H.R. 4790 · 108th Congress
Drug Importation Promotion and Safety Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
JohnSponsorNo cosponsors.
Drug Importation Promotion and Safety Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Drug Importation Promotion and Safety.
What it does: CRS summary · Introduced in House · Jul 9, 2004
Drug Importation Promotion and Safety Act - Amends the Federal Food, Drug, and Cosmetic Act to establish the Office of Drug Importation Promotion and Safety.
Allows a registered drug importation facility, pharmacy, Internet pharmacy, or wholesaler to import a Food and Drug Administration (FDA)-approved prescription drug from Canada or a permitted country.
Prohibits the commingling of domestic and imported prescription drugs.
Requires a pharmacy or Internet pharmacy that dispenses an imported prescription drug to label such drug accordingly.
Allows individuals to import prescription drugs from: (1) a registered Internet pharmacy; or (2) licensed pharmacies for personal use.
Allows the Secretary to suspend importation of a particular drug from a particular facility, pharmacy, wholesaler, or country.
Allows licensed Internet pharmacies to dispense prescription drugs. Sets forth licensing requirements for Internet pharmacies.
Makes interactive computer service providers and advertising service providers liable for violations under this Act if such a provider accepts advertising: (1) for a prescription drug from an unlicensed Internet pharmacy; or (2) stating that an individual does not need a prescription to obtain a prescription drug.
Requires the Secretary to: (1) require the adoption and use of electronic track and trace technology to identify each sale, purchase, or trade of a prescription drug; and (2) establish a network to provide prompt notification of counterfeit drugs and to facilitate the identification and reporting of such drugs.
Sets forth requirements for wholesalers, including requirements to identify the immediately previous distributor of record and all previous sales, purchases, or trades for imported prescription drugs.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Drug Importation Promotion and Safety Act
Latest action (Jul 19, 2004): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 9, 2004
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.